Cardinal addresses slow uptake of Medication Management Therapy

In a recent blog, Dr. Brad Tice discusses why Medication Management Therapy (MTM) isn’t being adopted at a quicker rate.

Advertisement

Medication Management Therapy focuses on the pharmacist delivering more than just counseling to a patient – it can also focus on a patient’s vitals over a period time or keeping up with a diabetic patient’s blood sugars levels in addition to monitoring medication.

While this seems like a worthwhile investment, there are a few barriers:
–    Timing Issues
–    Cost Allocation
–    Financial incentives

According to Dr. Tice, the savings from utilizing MTM appear outside the pharmacy in fewer hospital readmissions, ED visits and physician utilization.
Tice notes, “Failing to measure the full impact of MTM programs is difficult to do, yet doing so is a fatal analytical error.”

To read the blog in full, click here.

At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Leadership & Management

Advertisement

Comments are closed.